December 2, 2016
Oncolys BioPharma announced on November 30 that it has entered a license agreement with China’s Jiangsu Hengrui Medicine for its oncolytic virus Telomelysin. The deal will grant Hengrui Medicine exclusive rights to develop and market the product in China, Hong...read more